Camlin Fine Sciences' Q2 FY 2025-26 Quarterly Results

Result Summary

• Camlin Fine Sciences Ltd reported a 7.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 6.7%.
• Its expenses for the quarter were up by 6.1% QoQ and 8.7% YoY.
• The net profit increased 40.0% QoQ and decreased 87.1% YoY.
• The earnings per share (EPS) of Camlin Fine Sciences Ltd declined at 0.75 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

## Company Overview
Camlin Fine Sciences Ltd is a company engaged in the manufacturing and distribution of specialty chemicals. The company is known for its range of high-quality products, including antioxidants and performance chemicals, which serve a variety of industries such as food, feed, and pet nutrition. Camlin Fine Sciences has established a significant presence in the global market, catering to diverse customer needs with its innovative chemical solutions. As of the most recent updates, any major developments or shifts in strategic direction are not specified in the provided data.

## Revenue
In the second quarter of the fiscal year 2026 (Q2FY26), Camlin Fine Sciences Ltd reported a total income of ₹464.42 crores. This marks a quarter-over-quarter (QoQ) increase of 7.5% from ₹432.12 crores in Q1FY26. Additionally, there is a year-over-year (YoY) growth of 6.7% compared to the ₹435.07 crores recorded in Q2FY25. The upward trend in total income suggests a positive movement in the company's revenue generation capabilities over the observed periods.

## Profitability
Profitability for Camlin Fine Sciences Ltd during Q2FY26 shows a mixed performance. The company recorded a profit before tax of ₹0.27 crores, which is a significant improvement from a loss of ₹-5.15 crores in Q1FY26 and a loss of ₹-142.81 crores in Q2FY25. However, after accounting for a tax expense of ₹5.91 crores, the profit after tax stands at a loss of ₹-14.95 crores. This represents a 40.0% increase in losses QoQ from ₹-10.68 crores in Q1FY26, but an 87.1% reduction in losses YoY from ₹-116.11 crores in Q2FY25. Earnings per share (EPS) for Q2FY26 is reported at ₹-0.75, showing a QoQ decline of 44.2% from ₹-0.52 in Q1FY26 and a YoY improvement of 87.4% from ₹-5.93 in Q2FY25.

## Operating Metrics
In terms of operating expenses, Camlin Fine Sciences Ltd reported total expenses of ₹464.15 crores for Q2FY26. This reflects a 6.1% increase QoQ from ₹437.27 crores in Q1FY26 and an 8.7% increase YoY from ₹426.84 crores in Q2FY25. The data indicates ongoing operational expenditure that slightly exceeds total income for the quarter. The company's tax expense, recorded at ₹5.91 crores in Q2FY26, contrasts significantly with the previous quarter's negligible tax of ₹-0.01 crores and the tax benefit of ₹-26.20 crores in Q2FY25. This marks a drastic QoQ change of -59200.0% and a YoY change of -122.6%. These metrics reflect changes in the company's financial obligations and tax strategy over the periods analyzed.